Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Hyperthermia 20 Sarcoma 7 Uterine Cervical Neoplasms 4 Rectal Neoplasms 4 Prostatic Neoplasms 4 Head and Neck Neoplasms 4 Melanoma 3 Colonic Neoplasms 3 Carcinoma, Hepatocellular 3 Breast Neoplasms 3 Urinary Bladder Neoplasms 2 Ovarian Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Sarcoma, Synovial 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Salivary Gland Adenoma, Pleomorphic 1 Recurrence 1 Prehypertension 1 Prediabetic State 1 Polycystic Ovary Syndrome 1 Peritoneal Neoplasms 1 Pelvic Pain 1 Oropharyngeal Neoplasms 1 Obesity 1 Neurofibrosarcoma 1 Neoplasms, Radiation-Induced 1

Interventions

Bupivacaine 11 Ketamine 9 Ropivacaine 8 Acetaminophen 8 Morphine 7 Dexmedetomidine 7 Analgesics, Opioid 7 Lidocaine 6 Anesthesia, General 6 Saline Solution 5 Fentanyl 5 Anesthesia, Local 5 Acupuncture Therapy 5 parecoxib 4 Tramadol 4 Surveys and Questionnaires 4 Sodium Chloride 4 Ethanol 4 Analgesia, Epidural 4 Transcutaneous Electric Nerve Stimulation 3 Radiofrequency Ablation 3 Propofol 3 Oxycodone 3 Ketorolac 3 Control Groups 3 Anesthetics, Local 3 Therapeutics 2 Tea 2 Pregabalin 2 Magnesium Sulfate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Agnosia × Diathermy × Clear all

NCT04778631 2025-11-20

PERISAFE

Assistance Publique - Hôpitaux de Paris

Phase NA Completed

Hyperthermia, Agnosia, Neoplasm Metastasis, Pelvic Pain, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡